England’s Real-World Evidence Framework Coming Soon
HTA Body Says RWE Will Reduce Uncertainties & Improve Guidance
Executive Summary
England’s health technology appraisal body, NICE, will publish a framework that will help it deliver on its ambition to use real-world evidence to close knowledge gaps and improve technology evaluations.
You may also be interested in...
UK: RWD At Center Of NICE Five-Year Strategy
NICE will develop standards for using real world data as part of a new five-year strategic plan that the UK health technology assessment body hopes will make it a leader in the use of research and data.
German HTA Queries Polivy Benefits Amid Lack Of Evidence
Roche’s lymphoma drug Polivy could face pricing challenges in Germany as it undergoes a full benefit assessment.
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.